New meningococcal A vaccine is being introduced into Africa

@article{Mayor2010NewMA,
  title={New meningococcal A vaccine is being introduced into Africa},
  author={Susan Mayor},
  journal={BMJ : British Medical Journal},
  year={2010},
  volume={341}
}
  • S. Mayor
  • Published 24 November 2010
  • Medicine
  • BMJ : British Medical Journal
A new conjugate vaccine against meningococcal A costing only $0.5 (£0.3; €0.4) a dose that has been developed for use in Africa is about to be introduced for the first time in a national vaccination programme in Burkina Faso, researchers announced. The campaign to vaccinate all children and young adults from the ages of 1 to 29 years with the vaccine, MenAfriVac, will begin in Burkina Faso on 6 December. Niger and Mali will follow with similar vaccination campaigns. Countries in the so called… 
Update on Imminent Vaccines: Report of the APPA VU 2010: II
  • S. Karande
  • Medicine
    Indian journal of pediatrics
  • 2011
TLDR
The Asia Pacific Pediatric Association Vaccinology Update 2010 (APPA VU 2010) was held in Mumbai on November 13–14, 2010 and the interesting information about vaccines, namely, live-attenuated Japanese encephalitisirus vaccine, tetravalent dengue virus vaccine, conjugate typhoid vaccine and conjugates meningococcal A vaccine are discussed.
Pharmacovigilance Systems in Developing Countries: An Evaluative Case Study in Burkina Faso
TLDR
The aim of this study was to evaluate the early-stage pharmacovigilance system of Burkina Faso through a comprehensive and system-based approach with the prospect of identifying areas for improvements.
Modular Tools for High Throughput Process Development of Polysaccharide Vaccines
TLDR
An integrated approach to particle conditioning and depth filtration is developed, which has shortened the process development time and will facilitate the creation of more robust processes at pilot and commercial scales of operation.